Healthcare Experience


Our Healthcare experience includes 848 clients, with 43 partnered brands and 817 USAN/INN names. Below is our extensive portfolio, feel free to filter by clients, brands, category or USAN/INN Names.   ||  Click Here for Consumer/B2B Experience



CLIENTS BRANDS CATEGORY
Ferring PHARMACEUTICALS apraglutide Metabolic Disorders
FERA PHARMACEUTICALS AVACLYR * Ophthalmology
FOREST LABORATORIES AVYCAZ Antibiotic
FIVE PRIME THERAPEUTICS bemarituzumab Oncology
FOREST LABORATORIES BYSTOLIC * Cardiovascular
FIVE PRIME THERAPEUTICS cabiralizumab Oncology
FOREST LABORATORIES CAMPRAL Neurology
FOREST LABORATORIES CELEXA Neurology
FOREST LABORATORIES CONSTELLA * Gastrointestinal
FAMY CARE CONTINGENCY ONE Women's Health
FERRING PHARMACEUTICALS CORTIMENT * Gastrointestinal
FOREST LABORATORIES DALIRESP Respiratory
FGK REPRESENTATIVE SERVICE DZUVEO Neurology
FORUM PHARMACEUTICALS encenicline Neurology
Flex Pharma enexasogaol Neurology
FAMY CARE ESME 21 Women's Health
FAMY CARE ESME 28 Women's Health
FERRING PHARMACEUTICALS follitropin delta Women's Health
FORBES MEDI-TECH FORBES MEDI-TECH Corporate Identity
FAMY CARE INDAYO Women's Health
FRESENIUS-KABI KABIVEN Nutritional Agent
FREEDOM INNOVATIONS KINTERRA Medical Device
FOREST LABORATORIES LINZESS Gastrointestinal
FERX MAGNETARG Medical Device
FORTY SEVEN magrolimab Oncology
FERRING PHARMACEUTICALS merotocin Women's Health
FOREST LABORATORIES NAMENDA Neurology
FOREST LABORATORIES NAMENDA XR Neurology
FOREST LABORATORIES NAMZARIC Neurology
FERRING PHARMACEUTICALS NOCDURNA Nephrology
FERRING PHARMACEUTICALS olamkicept Immunology
FERRER INTERNACIONAL OZANEX * Antibiotic
FIBROGEN pamrevlumab Immunology
FRESENIUS PHOSLYRA * Nephrology
FERRING PHARMACEUTICALS PREPOPIK Gastrointestinal
FIBROGEN roxadustat Nephrology
FOREST LABORATORIES SAVELLA Women's Health
FERRING PHARMACEUTICALS SEPSIS-ACT Clinical Trial Name
FOREST LABORATORIES TEFLARO Antibiotic
FABRE KRAMER PHARMACEUTICALS TRAVIVO Neurology
FERRER INTERNACIONAL TRINOMIA Cardiovascular
FOREST LABORATORIES VIIBRYD * Neurology
FLEXION THERAPEUTICS ZILRETTA * Pain & Inflammation


* Denotes a comprehensive report of the safety regulatory research prepared by BI/DSI for submission of this name candidate to FDA, EMA, Health Canada, JMHLW, ANVISA, ROSZDRAVNADZOR, CDSCO, CFDA, KOREA MFDS, and/or other Regulatory Agencies.

Back to top